Dr. Anthony Chang, MD

NPI: 1407908825
Total Payments
$568,841
2024 Payments
$71,626
Companies
12
Transactions
861
Medicare Patients
765
Medicare Billing
$36,935

Payment Breakdown by Category

Other$405,805 (71.3%)
Consulting$74,459 (13.1%)
Travel$67,729 (11.9%)
Food & Beverage$18,567 (3.3%)
Education$2,282 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $302,378 101 53.2%
Honoraria $103,427 45 18.2%
Consulting Fee $74,459 18 13.1%
Travel and Lodging $67,729 370 11.9%
Food and Beverage $18,567 264 3.3%
Education $2,282 63 0.4%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $513,246 787 $0 (2024)
Apellis Pharmaceuticals, Inc. $19,553 21 $0 (2024)
Novartis Pharmaceuticals Corporation $14,606 15 $0 (2024)
GlaxoSmithKline, LLC. $14,604 23 $0 (2023)
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,905 2 $0 (2024)
Amicus Therapeutics, Inc. $2,621 2 $0 (2024)
Mallinckrodt Hospital Products Inc. $393.53 3 $0 (2024)
Amgen Inc. $293.82 3 $0 (2024)
Aurinia Pharma U.S., Inc. $235.64 2 $0 (2023)
Travere Therapeutics, Inc. $149.66 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $71,626 77 Alexion Pharmaceuticals, Inc. ($45,665)
2023 $72,704 79 Alexion Pharmaceuticals, Inc. ($60,514)
2022 $85,561 92 Alexion Pharmaceuticals, Inc. ($81,016)
2021 $51,088 70 Alexion Pharmaceuticals, Inc. ($49,248)
2020 $34,850 39 Alexion Pharmaceuticals, Inc. ($34,850)
2019 $117,940 207 Alexion Pharmaceuticals, Inc. ($106,881)
2018 $120,086 209 Alexion Pharmaceuticals, Inc. ($120,086)
2017 $14,985 88 Alexion Pharmaceuticals, Inc. ($14,985)

All Payment Transactions

861 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/12/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $149.66 General
12/11/2024 Apellis Pharmaceuticals, Inc. Empaveli (Drug) Honoraria Cash or cash equivalent $3,432.00 General
Category: Hematology
12/03/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $134.89 General
Category: Inflammation
12/02/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $132.47 General
11/08/2024 Apellis Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $7,722.00 General
11/08/2024 Apellis Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $739.00 General
11/08/2024 Apellis Pharmaceuticals, Inc. Food and Beverage In-kind items and services $29.30 General
11/05/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,900.00 General
10/30/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $700.00 General
Category: Immunology
10/29/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $700.00 General
Category: Immunology
10/29/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $107.74 General
Category: Inflammation
10/23/2024 Alexion Pharmaceuticals, Inc. SOLIRIS (Biological) Education In-kind items and services $49.99 General
Category: Rare Disease
10/09/2024 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,520.00 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $358.26 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $268.54 General
10/09/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $111.33 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $70.11 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $63.54 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $52.68 General
10/09/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $4.00 General
10/02/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $25.05 General
09/11/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $52.00 General
09/11/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $33.50 General
09/11/2024 Alexion Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $27.04 General
09/10/2024 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,520.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 244 475 $98,821 $10,959
2022 5 182 359 $70,752 $8,392
2021 5 199 421 $81,885 $9,988
2020 5 140 305 $57,367 $7,597
Total Patients
765
Total Services
1,560
Medicare Billing
$36,935
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2023 34 178 $36,046 $4,174 11.6%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 67 80 $22,368 $2,367 10.6%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2023 52 56 $15,128 $1,623 10.7%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2023 61 130 $11,496 $1,270 11.0%
88348 Electron microscopy for diagnosis Facility 2023 19 19 $10,607 $1,186 11.2%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 11 12 $3,176 $338.04 10.6%
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2022 21 129 $25,103 $3,113 12.4%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 52 58 $15,700 $1,795 11.4%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2022 40 43 $11,238 $1,281 11.4%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2022 52 112 $9,588 $1,141 11.9%
88348 Electron microscopy for diagnosis Facility 2022 17 17 $9,123 $1,061 11.6%
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2021 32 192 $35,846 $4,538 12.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2021 51 58 $15,070 $1,786 11.8%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2021 47 51 $12,806 $1,515 11.8%
88348 Electron microscopy for diagnosis Facility 2021 18 19 $9,832 $1,124 11.4%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2021 51 101 $8,331 $1,026 12.3%
88350 Antibody evaluation Facility 2020 22 145 $26,162 $3,655 14.0%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 35 39 $9,745 $1,241 12.7%
88346 Antibody evaluation Facility 2020 32 32 $7,719 $996.89 12.9%
88348 Electron microscopy for diagnosis Facility 2020 16 16 $7,948 $948.18 11.9%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2020 35 73 $5,793 $755.74 13.0%

About Dr. Anthony Chang, MD

Dr. Anthony Chang, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Burr Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407908825.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Chang, MD has received a total of $568,841 in payments from pharmaceutical and medical device companies, with $71,626 received in 2024. These payments were reported across 861 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($302,378).

As a Medicare-enrolled provider, Chang has provided services to 765 Medicare beneficiaries, totaling 1,560 services with total Medicare billing of $36,935. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

Products in Payments

  • SOLIRIS (Drug) $93,442
  • ULTOMIRIS (Biological) $21,033
  • Ultomiris (Drug) $15,155
  • SOLIRIS (Biological) $9,556
  • BENLYSTA (Biological) $7,066
  • Empaveli (Drug) $3,432
  • Fabhalta (Drug) $1,400
  • ACTHAR (Biological) $393.53
  • TAVNEOS (Drug) $242.63
  • LUPKYNIS (Drug) $235.64
  • PURIFIED CORTROPHIN GEL (Drug) $120.69
  • JESDUVROQ (Drug) $119.49
  • TECENTRIQ (Biological) $113.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.